Alex Schepart
3PUBLICATIONS
12CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (3)
Sort by Publication Date:
|Feb 28, 2024
Elranatamab efficacy in MagnetisMM-3 compared with real-world control arms in triple-class refractory multiple myeloma.Luciano J Costa, Thomas W LeBlanc, Hans Tesch
|Feb 13, 2024
A matching-adjusted indirect comparison of the efficacy of elranatamab versus teclistamab in patients with triple-class exposed/refractory multiple myeloma.Isha Mol, Yannan Hu, Thomas W LeBlanc
|Dec 11, 2023
A matching-adjusted indirect comparison of the efficacy of elranatamab versus physician's choice of treatment in patients with triple-class exposed/refractory multiple myeloma.Isha Mol, Yannan Hu, Thomas W LeBlanc
Pageof 1
Frequent Collaborators
3 joint publications
Thomas W LeBlanc
2 joint publications
Isha Mol
2 joint publications
Haitao Chu
1 joint publications
Luciano J Costa
1 joint publications
Hans Tesch
1 joint publications
Pieter Sonneveld
1 joint publications
Ryan P Kyle
1 joint publications
Liliya Sinyavskaya
1 joint publications
Patrick Hlavacek
1 joint publications
Aster Meche
